Accuray (ARAY) Net Cash Flow (2010 - 2026)
Accuray's (ARAY) quarterly Net Cash Flow came in at -$3.0 million in Q1 2026, down 133.16% year-on-year from $9.0 million in Q1 2025, and up 86.29% quarter-over-quarter from -$21.9 million in Q4 2025.
Accuray (ARAY) Net Cash Flow (2010 - 2026) Analysis & Trends
Accuray's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$3.0 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 133.16% year-over-year to -$3.0 million in Q1 2026; TTM through Mar 2026 was -$17.0 million, a 481.6% decrease from a year earlier, with the FY2025 full-year figure at -$9.9 million, up 49.04% from the prior year.
- Net Cash Flow improved to -$3.0 million in Q1 2026 per ARAY's latest filing, from -$21.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $9.0 million in Q1 2025 and bottomed at -$28.2 million in Q1 2024.
- The 5-year median for Net Cash Flow is -$6.6 million (2023), against an average of -$7.4 million.
- Biggest YoY gain for Net Cash Flow was 190.88% in 2024; the steepest drop was 7862.81% in 2024.
- Year by year, Net Cash Flow stood at -$15.3 million in 2022, then soared by 56.79% to -$6.6 million in 2023, then surged by 190.88% to $6.0 million in 2024, then sank by 464.58% to -$21.9 million in 2025, then jumped by 86.29% to -$3.0 million in 2026.
- Per Business Quant, the three latest ARAY Net Cash Flow figures stand at -$3.0 million (Q1 2026), -$21.9 million (Q4 2025), and $7.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | -3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.00 Mn |
| Mar 31, 2026 | -3.00 Mn |
| Dec 31, 2025 | -21.86 Mn |
| Dec 31, 2025 | -21.86 Mn |
| Sep 30, 2025 | 7.88 Mn |
| Sep 30, 2025 | 7.88 Mn |
| Mar 31, 2025 | 9.04 Mn |
| Mar 31, 2025 | 9.04 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | -10.59 Mn |
| Sep 30, 2024 | -10.59 Mn |
| Mar 31, 2024 | -28.18 Mn |
| Mar 31, 2024 | -28.18 Mn |
| Dec 31, 2023 | -6.60 Mn |
| Dec 31, 2023 | -6.60 Mn |
| Sep 30, 2023 | -11.18 Mn |
| Sep 30, 2023 | -11.18 Mn |
| Mar 31, 2023 | 363,000.00 |
| Mar 31, 2023 | 363,000.00 |